Affiliation:
1. Department of Facial Plastic and Reconstructive Surgery Eye & ENT Hospital of Fudan University Shanghai China
2. ENT Institute Eye & ENT Hospital of Fudan University Shanghai China
3. Department of Radiology Eye & ENT Hospital of Fudan University Shanghai China
4. GeneMind Biosciences Company Limited Shenzhen China
5. NHC Key Laboratory of Hearing Medicine Fudan University Shanghai China
Abstract
AbstractBackgroundMandibulofacial dysostosis with microcephaly (MFDM, OMIM# 610536) is a rare monogenic disease that is caused by a mutation in the elongation factor Tu GTP binding domain containing 2 gene (EFTUD2, OMIM* 603892). It is characterized by mandibulofacial dysplasia, microcephaly, malformed ears, cleft palate, growth and intellectual disability. MFDM can be easily misdiagnosed due to its phenotypic overlap with other craniofacial dysostosis syndromes. The clinical presentation of MFDM is highly variable among patients.MethodsA patient with craniofacial anomalies was enrolled and evaluated by a multidisciplinary team. To make a definitive diagnosis, whole‐exome sequencing was performed, followed by validation by Sanger sequencing.ResultsThe patient presented with extensive facial bone dysostosis, upward slanting palpebral fissures, outer and middle ear malformation, a previously unreported orbit anomaly, and spina bifida occulta. A novel, pathogenic insertion mutation (c.215_216insT: p.Tyr73Valfs*4) in EFTUD2 was identified as the likely cause of the disease.ConclusionsWe diagnosed this atypical case of MFDM by the detection of a novel pathogenetic mutation in EFTUD2. We also observed previously unreported features. These findings enrich both the genotypic and phenotypic spectrum of MFDM.
Funder
National Key Research and Development Program of China
Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
National Natural Science Foundation of China
Science and Technology Commission of Shanghai Municipality